MedTrace Logo

Study to Assess Safety, Tolerability and Pharmacokinetics After Single and Multiple Doses of AZD1446 to Japanese Subject

NCT01021189 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2010-06-10

No results posted yet for this study

Summary

The primary aim of this study is to assess the safety and tolerability of AZD1446 following single and multiple ascending doses of an orally administered solution of AZD1446 in healthy young and elderly Japanese subjects.

Conditions

  • Healthy

Interventions

DRUG

AZD1446

Oral solution Dose single and followed by 7-day multiple dosing.Specific doses depend on panel.

DRUG

Placebo

Oral solution Dose single and followed by 7-day multiple dosing.

Sponsors & Collaborators

Principal Investigators

  • Björn Paulsson, MD, PhD · AstraZeneca R&D Södertälje

  • Shunji Matsuki, MD, PhD · Kyusyu Clinical Phramacology Research Clinic

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01021189 on ClinicalTrials.gov